Lung Cancer Considered

The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the inaugural joint IASLC/EMRO workshop took place at the 2026 World Conference on Lung Cancer (WCLC) in Seoul.

In this episode, Dr. Nagla Karim discusses highlights from the workshop in Arabic with Dr. Hesham Elghazaly, Dr. Arafat Tfayli, Dr. Bashir Abu Aqeel, Dr. Riad Abdel Jalil, Dr. Adda Bounedjar, and Dr. Rasha Aboelhassan.

Guests:
Nagla Karim, MD
Professor of Medicine
Director of Thoracic Oncology and Phase I Programs
George Washington University

Hesham Elghazaly, MD
Professor of Clinical Oncology
Ain Shams University

Arafat Tfayli, MD
Chief of Hematology/Oncology and Professor of Clinical Medicine
American University of Beirut Medical Center

Bashir Abu Aqeel, MD
Medical Oncologist
Augusta Victoria Hospital

Riad Abdel Jalil, MD
Thoracic Surgeon
King Hussein Cancer Center

Adda Bounedjar, MD
Professor of Medical Oncology
Blida 1 University

Rasha Aboelhassan, MD
Senior Oncology Consultant
Nasser Institute for Research and Treatment

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
In this episode, host Dr. Chul Kim moderates a discussion in Korean about breakthrough advances in thoracic oncology presented at the conference with Dr. Ji-Youn Han, Dr. Tae Min Kim, and Dr. Sehhoon Park.

Guests:

Ji-Youn Han, MD, PhD
Professor
National Cancer Center of Korea
X: @oncologyhan

Tae Min Kim, MD, PhD
Professor
Seoul National University Hospital
No Social

Sehhoon Park, MD, PhD
Division of Hematology-Oncology, Department of Medicine
Samsung Medical Center, Sungkyunkwan University School of Medicine
LinkedIn: https://www.linkedin.com/in/sehhoon-park/

In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and conversations that caught their attention at the meeting.

They reflect on access to new therapies, the importance of involving patient advocates early in clinical trial design, and how stronger communication between patients and providers can improve care. Plus, hear what they look for in new research and their perspectives on topics such as survivorship research and exercise oncology.

Guests:
Dr. Sydney Barned
Physician and Patient Advocate
Living with Stage IV ALK-positive lung cancer

Yvonne Diaz
Co-founder and Chair, Oncogene Cancer Research
Board Member, ALK Positive Inc.

Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and clinical expertise between the regions.

Dr. Chul Kim, Dr. Stephen Liu, Dr. Yuanyuan Zhao, and Dr. Caicun Zhou discuss key research highlights presented at WCLC and explore why lung cancer research is advancing rapidly in China, plus how stronger global collaboration can shape the future of thoracic oncology.

Guests:
Dr. Chul Kim
Director of Thoracic Oncology
Georgetown University, Washington, DC

Dr. Yuanyuan Zhao
Medical Oncologist & Chief Physician
Sun Yat-Sen University Cancer Center

Dr. Caicun Zhou
Professor, Chief Physician, and Director of Medical Oncology
Shanghai Pulmonary Hospital, Tongji University School of Medicine

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and lung cancer screening — with a focus on what APPs can take back to the clinic.

Laura Macke, Stephanie McDonald, and Dr. Mary Pasquinelli discuss the studies and advances that caught their attention, including how these developments will affect patient conversations, treatment decisions, and the day-to-day work of APPs.

Guests:
Laura A. Macke, MS, FNP-C, AOCNP
Nurse Practitioner
Medstar Georgetown Cancer Institute
Washington, DC

Stephanie McDonald, MSN, FNP-BC, AOCNP
Thoracic Oncology Nurse Practitioner
Dana-Farber Cancer Institute
Boston, MA

Mary Pasquinelli, DNP, APRN, CTTS
Lead Nurse Practitioner and Director of the Lung Screening Program
University of Illinois Chicago